The patented invention relates to techniques for fabricating composite polymer microstructures and not applicable to the field of Textile Engineering.
The patented invention relates to the micro-fabrication of imprinted polymeric structures with well-defined geometry for the fabrication of bioactive scaffolds. The scaffolds can be used both as substrates for the study and fabrication of functional tissue substitutes and as biosensors.
The present technology is a prosthetic elevation device that allows a fixation of the new tympanic membrane for the creation of a larger sounding (tympanic) box after tympanoplasty surgery, without damaging the facial nerve.
The present invention relates to a device for the electrical characterization of cellular constructs, featured by electrodes solidly integrated within the culture chamber of the constructs.
The present invention concerns the synthesis of small molecules, obtained by a totally innovative process, characterized by a stimulatory effect on the secretion of GLP-1, a gastrointestinal hormone.
The invention relates to a sensorized high throughput bioreactor, that can be placed in series and/or parallel with similar systems, to expose cultures of the same or different cell groups to mechanical stimuli, such as hydrodynamic pressure and shear stress, simulating physiological and pathological conditions present within an organism.
The invention relates to a sensorized high throughput bioreactor, that can be placed in series and/or parallel with similar systems, to subject vascular conduits of different sizes to chemical-physical, mechanical and electromagnetic stimuli, simulating physiological and pathological conditions present within an organism.
The present invention provides an in vitro and ex vivo method using novel diagnostic probes with a specific spectrum detected by infrared (IR) spectroscopy.
The present invention relates to the automation of data interpretation from a chromatography analysis, such specifically the retention times and concentration values of analytes in a mixture.
The present invention relates to the development of novel isoindoline derivatives as activators of AMPK (Adenosine MonoPhosphate-activated protein Kinase), a key enzyme in cellular metabolism. The compounds, with original chemical structure, can be usefully employed for the prevention and treatment of metabolic disorders, such as type II diabetes and obesity, as well as immune-mediated inflammatory diseases and cancer.
